These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10518199)

  • 1. Importance of chemotherapy scheduling: pieces of the puzzle.
    Hryniuk W
    Cancer Invest; 1999; 17(7):545-6. PubMed ID: 10518199
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential innovations in scheduling of cancer chemotherapy.
    Norton L; Day R
    Important Adv Oncol; 1991; ():57-72. PubMed ID: 1869282
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical cancer chronotherapy trials: a review.
    Bjarnason GA
    J Infus Chemother; 1995; 5(1):31-7. PubMed ID: 7634175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifying risks of secondary leukemias: is drug scheduling important?
    Karp JE; Smith MA
    J Natl Cancer Inst; 1996 Dec; 88(24):1787-9. PubMed ID: 8961963
    [No Abstract]   [Full Text] [Related]  

  • 5. Automating the drug scheduling of cancer chemotherapy via evolutionary computation.
    Tan KC; Khor EF; Cai J; Heng CM; Lee TH
    Artif Intell Med; 2002 Jun; 25(2):169-85. PubMed ID: 12031605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of dose and schedule in cancer chemotherapy: epithelial ovarian cancer.
    Mainwaring PN; Gore ME
    Anticancer Drugs; 1995 Oct; 6 Suppl 5():29-41. PubMed ID: 8845493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Principles for adjuvant and neoadjuvant chemotherapy].
    Fukuoka M; Tsuchiya R
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():333-7. PubMed ID: 7986112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of dose intensity in the outcome of chemotherapy.
    Hryniuk WM
    Important Adv Oncol; 1988; ():121-41. PubMed ID: 3042601
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional chemotherapy: revisited.
    Markman M
    J Cancer Res Clin Oncol; 1996; 122(1):1-2. PubMed ID: 8543586
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?
    Crown J
    Lancet; 2003 Aug; 362(9385):677-8. PubMed ID: 12957087
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose: a critical factor in cancer chemotherapy.
    Frei E; Canellos GP
    Am J Med; 1980 Oct; 69(4):585-94. PubMed ID: 6999898
    [No Abstract]   [Full Text] [Related]  

  • 12. The importance of drug scheduling in cancer chemotherapy: etoposide as an example.
    Hande KR
    Stem Cells; 1996 Jan; 14(1):18-24. PubMed ID: 8820946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of dose and schedule in chemotherapy for small cell lung cancer.
    Ranson M; Thatcher N
    Anticancer Drugs; 1995 Oct; 6 Suppl 5():53-63. PubMed ID: 8845495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a rational design for metronomic chemotherapy dosing be devised?
    Maraveyas A; Lam T; Hetherington JW; Greenman J
    Br J Cancer; 2005 Apr; 92(8):1588-90. PubMed ID: 15846302
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms to improve chemotherapy effectiveness.
    Young RC
    Cancer; 1990 Feb; 65(3 Suppl):815-22. PubMed ID: 2406004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will increases in chemotherapy dose intensity improve outcome of patients with common malignancies?
    Tannock I
    Am J Med; 1995 Dec; 99(6A):68S-69S. PubMed ID: 8585542
    [No Abstract]   [Full Text] [Related]  

  • 17. Scheduling of anticancer drugs: timing may be everything.
    Van der Veldt AA; Lammertsma AA; Smit EF
    Cell Cycle; 2012 Dec; 11(23):4339-43. PubMed ID: 23032365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.
    Stull DM; Bilmes R; Kim H; Fichtl R
    Am J Health Syst Pharm; 2005 Jan; 62(1):83-7. PubMed ID: 15658078
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal schedule of paclitaxel: weekly is better.
    Gonzalez-Angulo AM; Hortobagyi GN
    J Clin Oncol; 2008 Apr; 26(10):1585-7. PubMed ID: 18375889
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
    Köstler WJ; Brodowicz T; Zielinski CC;
    J Natl Cancer Inst; 2010 Feb; 102(3):207; author reply 207-8. PubMed ID: 20054016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.